Reducing dead space ensures the patient gets a full dose without wastage
A 2023 analysis in Obesity (Claridy et al.) found that payers denied 41% of prior authorizations for "inadequate weight-loss attempt documentation" even when patients had documented supervised programs, because the notes didn't include specific language like "comprehensive" or "intensive." The pattern we see: prior authorizations submitted by bariatric medicine specialists have a 78% approval rate, while those submitted by primary care physicians have a 58% approval rate
According to the MHRA-approved SmPC, semaglutide works by binding to GLP-1 receptors in multiple tissues, including the pancreas, where it enhances glucose-dependent insulin secretion, and in the brain, where it reduces appetite and food intake through effects on satiety centres
Whether to start, what dose, how to manage side effects, when and how to stop, and what your bloods say
Schedule a consultation today to explore your options.